| 1 |
34405020 | The Differential Antitumor Activity of 5-Aza-2'-deoxycytidine in Prostate Cancer DU145, 22RV1, and LNCaP Cells. | 2021 |
2 |
| 2 |
34837933 | Investigation the Cytotoxicity of 5-AZA on Acute Lymphoblastic Leukemia Cell Line In Vitro and Characterization the Underlying Molecular Mechanisms of Cell Death and Motility. | 2021 Nov 1 |
1 |
| 3 |
25487600 | Overexpression of GYS1, MIF, and MYC is associated with adverse outcome and poor response to azacitidine in myelodysplastic syndromes and acute myeloid leukemia. | 2015 Apr |
1 |
| 4 |
25061731 | 5-Azacytidine suppresses the proliferation of pancreatic cancer cells by inhibiting the Wnt/β-catenin signaling pathway. | 2014 Jul 4 |
1 |
| 5 |
25319547 | 5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion. | 2014 Dec |
2 |
| 6 |
22672838 | Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma. | 2012 Jun 6 |
2 |
| 7 |
23063977 | All-trans retinoic acid combined with 5-Aza-2'-deoxycitidine induces C/EBPα expression and growth inhibition in MLL-AF9-positive leukemic cells. | 2012 Nov 16 |
1 |
| 8 |
23300844 | Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. | 2012 |
1 |
| 9 |
10914736 | Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT. | 2000 Jul |
2 |
| 10 |
2425967 | Methylation and expression of c-myc and c-abl oncogenes in human leukemic K562 cells before and after treatment with 5-azacytidine. | 1986 |
1 |